Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:333-335
doi: 10.1161/CIRCULATIONAHA.107.746917
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferguson, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferguson, T. B., Jr
Related Collections
Right arrow Health policy and outcome research
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease

(Circulation. 2008;117:333-335.)
© 2008 American Heart Association, Inc.


Editorial

On the Evaluation of Intervention Outcome Risks for Patients With Ischemic Heart Disease

T. Bruce Ferguson, Jr, MD

From the Department of Cardiovascular Sciences, Brody School of Medicine at ECU, Greenville, NC.

Correspondence to T. Bruce Ferguson, Jr, MD, Department of Cardiovascular Sciences, East Caroline Heart Institute, 600 Moye Blvd, TA 255, Greenville, NC 27834. E-mail fergusont@ecu.edu


Key Words: Editorials • revascularization • risk factors • outcomes research


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Risk is defined in the Oxford Pocket American Dictionary of Current English as "a chance or possibility of danger, loss, injury, etc."1 The evaluation of clinical risk and benefit is a mainstay of all clinical investigation in medicine. More recently, it is slowly becoming a component of everyday clinical care. In this issue of Circulation, Singh et al2 potentially advance the evaluation of risk in the domain of ischemic heart disease.

Article p 356

Because procedural mortality has been such an important outcome in the surgical revascularization of coronary artery disease, the assessment of preoperative risk has been an important focus of attention for many years. Large US regional and national databases, such as the Northern New England Cardiovascular Disease Study Group,3 the New York State cardiac surgery database,4 and the Society of Thoracic Surgeons’ National Cardiac Database (STS NCD),5 have developed relatively sophisticated multivariable models to predict mortality risk across the entire spectrum of coronary artery bypass grafting (CABG) patients. Similar risk models have been developed outside the United States, most notably from the European Cardiac Surgery database.6

Model performance has been tested and continually refined within these databases. Over the years, it has become clear that a core group of preoperative risk factors and conditions contribute a majority of the inherent mortality risk in these models. This has led to the concept that specific risk models can be applied to other CABG data sets. Nashef et al7 tested the performance of the EuroSCORE model against a cohort . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
HeartHome page
M. A de Belder and L. Hamilton
Evaluating risks and benefits in coronary revascularisation--a very imperfect art?
Heart, January 1, 2009; 95(1): 6 - 8.
[Full Text] [PDF]